ArticleJCO global oncology2023

Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP).

Anant Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.